Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical IllnessDELTA-EXTNCT07634783
Delta Pocc During Spontaneous Breathing Trial to Predict Extubation Failure in Mechanically Ventilated Adults (DELTA-EXT)
An observational study of Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness, run by Sanatorio Parque, Argentina at 1 site in Argentina.
Trial summary
This prospective observational single-center study will evaluate whether dynamic respiratory stress estimated by delta airway occlusion pressure deflection (Delta Pocc) during a standardized spontaneous breathing trial can predict extubation failure in mechanically ventilated adult intensive care unit patients. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness
- What is being tested?
- Delta Pocc Measurement During Spontaneous Breathing Trial
- How many people
- 120 participants
- Where
- 1 siteArgentina
- Study dates
- Aug 2026to Aug 2027
- How long will I take part?
- 2 Days
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult intensive care unit patients receiving invasive mechanical ventilation for at least 24 hours who are considered clinically ready for a spontaneous breathing trial as part of routine weaning assessment.
Who may be able to join
- Age 18 years or older
- Invasive mechanical ventilation for at least 24 hours
- Clinical indication for spontaneous breathing trial according to the treating clinical team
- Hemodynamic and clinical stability
- Technical feasibility for respiratory physiological measurements, including expiratory occlusion maneuver
Who cannot join
- Significant hemodynamic instability
- Severe uncontrolled hypoxemia
- Major cardiac arrhythmias
- Agitation or patient-ventilator asynchrony preventing reliable measurements
- Significant air leak interfering with respiratory measurements
- Technical inability to perform expiratory occlusion maneuver
- Limitation of life-sustaining treatment
- Incomplete primary outcome follow-up
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Argentina1 site
Sanatorio Parque
Rosario, Santa Fe Province, 2000
Gabriel A Musso, PT, MSc, +54 9 3413068143, gmusso@ugr.edu.ar
Maria C Gomez, PT, MSc, +5493415462918, cgomez@ugr.edu.ar
About this study
Official title: Prospective Observational Single-Center Physiological Study Evaluating Dynamic Stress Estimated by Delta Pocc During a Pressure Support Spontaneous Breathing Trial (PSV 8 cmH2O, PEEP 0 cmH2O) as a Predictor of Extubation Failure in Mechanically Ventilated Adult ICU Patients
This prospective observational single-center study will evaluate whether dynamic respiratory stress estimated by delta airway occlusion pressure deflection (Delta Pocc) during a standardized spontaneous breathing trial can predict extubation failure in mechanically ventilated adult intensive care unit patients.
Liberation from invasive mechanical ventilation is a critical step in ICU care. Although spontaneous breathing trials are routinely used to assess readiness for extubation, some patients may successfully complete the trial despite experiencing excessive respiratory effort and physiological stress, which may increase the risk of extubation failure.
Read more
This study will include adult ICU patients who have received invasive mechanical ventilation for at least 24 hours and are considered ready for a spontaneous breathing trial according to the treating clinical team. During the trial, respiratory, ventilatory, and hemodynamic variables will be recorded at predefined time points, including measurements of Delta Pocc as a non-invasive estimate of inspiratory effort and dynamic stress.
The primary outcome is extubation failure within 48 hours after extubation, defined as reintubation and/or the need for rescue non-invasive respiratory support due to post-extubation respiratory deterioration.
The study aims to determine whether this physiological measurement may improve risk stratification during weaning and complement conventional clinical decision-making.
Read the detailed description
Background
Liberation from invasive mechanical ventilation requires integration of clinical, hemodynamic, gas exchange, and physiological criteria. The spontaneous breathing trial (SBT) is a standard component of the weaning process and is commonly used to assess readiness for extubation. However, conventional clinical parameters may not fully capture the true respiratory workload experienced by the patient during the trial.
Some patients may tolerate a spontaneous breathing trial according to standard criteria while still developing excessive inspiratory effort and elevated dynamic respiratory stress, potentially predisposing them to post-extubation respiratory failure. Identifying these patients before extubation remains a major clinical challenge.
Delta airway occlusion pressure deflection (Delta Pocc), obtained during a brief expiratory occlusion maneuver, has emerged as a non-invasive physiological surrogate for inspiratory effort and dynamic transpulmonary stress. Incorporating this measurement into routine spontaneous breathing trial assessment may improve identification of patients at increased risk of extubation failure.
Objective
The primary objective of this study is to evaluate the predictive ability of Delta Pocc measured during a standardized spontaneous breathing trial to identify patients at risk of extubation failure within 48 hours.
Secondary objectives include:
To describe the temporal evolution of Delta Pocc and other respiratory physiological variables during the spontaneous breathing trial.
To compare respiratory effort and physiological measurements between patients with successful extubation and those with extubation failure.
To explore the discriminatory performance of Delta Pocc compared with conventional weaning variables.
To evaluate associations between Delta Pocc and clinically relevant outcomes including reintubation, rescue respiratory support, ICU length of stay, hospital length of stay, and mortality.
Study Design
This is a prospective, observational, single-center physiological study conducted in the adult intensive care unit of Sanatorio Parque.
The study does not modify standard clinical management. Participation will not delay extubation decisions or replace the clinical judgment of the treating team.
Study Population
Adult ICU patients receiving invasive mechanical ventilation for at least 24 hours who meet clinical criteria for a spontaneous breathing trial according to routine clinical practice will be eligible.
Inclusion Criteria Age 18 years or older Invasive mechanical ventilation for at least 24 hours Clinical indication for spontaneous breathing trial Hemodynamic and clinical stability Technical feasibility for physiological measurements Exclusion Criteria Significant hemodynamic instability Severe uncontrolled hypoxemia Major arrhythmias Agitation or patient-ventilator asynchrony preventing reliable measurements Significant air leak Technical inability to perform expiratory occlusion maneuver Limitation of life-sustaining treatment Procedures
Baseline respiratory, ventilatory, and hemodynamic variables will be recorded under current ventilatory settings.
A standardized spontaneous breathing trial will then be performed using:
Pressure support ventilation (PSV): 8 cmH2O Positive end-expiratory pressure (PEEP): 0 cmH2O
Measurements will be recorded at:
Baseline 15 minutes 30 minutes
Collected variables include:
Delta Pocc P0.1 Estimated inspiratory muscle pressure Negative inspiratory force Respiratory rate Rapid shallow breathing index Minute ventilation Peak airway pressure Mean airway pressure Oxygen saturation Heart rate Blood pressure Mean arterial pressure Fraction of inspired oxygen
Extubation decisions, preventive non-invasive respiratory support, rescue respiratory support, and reintubation will remain entirely at the discretion of the treating clinical team according to institutional practice.
Outcomes Primary Outcome
Extubation failure within 48 hours after extubation, defined as:
Reintubation, and/or Rescue non-invasive respiratory support due to respiratory deterioration after extubation Secondary Outcomes Spontaneous breathing trial success or failure Cause of spontaneous breathing trial failure Preventive non-invasive respiratory support Reintubation Rescue non-invasive respiratory support Duration of mechanical ventilation ICU length of stay Total hospital length of stay In-hospital mortality Statistical Considerations
The study is designed to evaluate the discriminative performance of Delta Pocc as a predictor of extubation failure.
Receiver operating characteristic (ROC) analysis will be used to assess predictive performance. Repeated physiological measurements will be analyzed using appropriate repeated-measures statistical methods. Multivariable logistic regression may be performed if the number of outcome events is sufficient.
A planned sample size of approximately 110 to 120 patients is expected to provide adequate event capture for exploratory predictive modeling.
Safety
This is a minimal-risk observational study. The only study-specific physiological maneuver is a brief expiratory occlusion measurement performed within standard ventilatory monitoring conditions.
No investigational drugs or devices are involved.
- Conditions
- Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness
- Being tested
- Delta Pocc Measurement During Spontaneous Breathing Trial
- Keywords
- ΔPocc Spontaneous Breathing Trial Extubation Failure Weaning Respiratory Effort
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Delta Pocc Measurement During Spontaneous Breathing TrialDiagnostic test
Delta airway occlusion pressure deflection will be measured during a standardized spontaneous breathing trial using pressure support ventilation of 8 cmH2O and PEEP of 0 cmH2O. Delta Pocc will be obtained through a brief expiratory occlusion maneuver and analyzed as a non-invasive physiological estimate of inspiratory effort and dynamic respiratory stress. The measurement will not replace clinical judgment or modify standard extubation decisions.
| Study group | Role | What they receive |
|---|---|---|
| Mechanically Ventilated Adult ICU Patients Undergoing Spontaneous Breathing Trial | Not described Receives: Diagnostic Test: Delta Pocc Measurement During Spontaneous Breathing Trial |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Participants With Extubation Failure Within 48 Hours
Number of participants experiencing extubation failure, defined as reintubation and/or the need for rescue non-invasive respiratory support due to respiratory deterioration after extubation.
Measured: Within 48 hours after extubation
Secondary outcomes (6)
Change in Delta Pocc During the Spontaneous Breathing Trial
Delta airway occlusion pressure deflection (Delta Pocc) measured at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial. The change from baseline and the highest value recorded during the trial will be analyzed.
Measured: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
P0.1 During the Spontaneous Breathing Trial
Airway occlusion pressure measured 100 milliseconds after the onset of inspiration (P0.1) at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial.
Measured: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Number of Participants Requiring Reintubation
Number of participants requiring reintubation due to post-extubation respiratory failure.
Measured: Within 48 hours after extubation
Number of Participants Requiring Rescue Non-Invasive Respiratory Support
Number of participants requiring rescue non-invasive ventilation (NIV) and/or high-flow nasal oxygen therapy (HFNO) because of respiratory deterioration following extubation.
Measured: Within 48 hours after extubation
Intensive Care Unit Length of Stay
Total number of days spent in the intensive care unit from ICU admission until ICU discharge.
Measured: Through ICU discharge, an average of 30 days
Number of Participants Who Died During Hospitalization
Number of participants who died during the index hospitalization.
Measured: Through hospital discharge, an average of 60 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jun 2026
- Study startAug 2026 (estimated)
- Primary completionAug 2027 (estimated)
- Study completionAug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical IllnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 120 participants (estimated)
- Target duration
- 2 Days
Sponsor and investigators
- Lead sponsor
- Sanatorio Parque, Argentina
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Musso Gabriel Andres, Sanatorio Parque, Argentina
- Investigators
- Gabriel A Musso, PT, MSc, Principal investigator, Sanatorio Parque
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07634783
- Sponsor's protocol ID
- SP-DELTAPOCC-EXTFAIL-2026
- Other IDs
- SP-DELTAPOCC-EXTFAIL-2026
- Acronym
- DELTA-EXT
- Status last verified
- Jun 2026
- First submitted
- 27 May 2026
- Last updated
- 25 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data are not planned to be shared because this is a single-center observational study and no formal institutional data-sharing infrastructure is currently in place. De-identified aggregate study results will be reported in scientific publications.
Publications
Thille AW, Gacouin A, Coudroy R, Ehrmann S, Quenot JP, Nay MA, Guitton C, Contou D, Labro G, Reignier J, Pradel G, Beduneau G, Dangers L, Saccheri C, Prat G, Lacave G, Sedillot N, Terzi N, La Combe B, Mira JP, Romen A, Azais MA, Rouze A, Devaquet J, Delbove A, Dres M, Bourenne J, Lautrette A, de Keizer J, Ragot S, Frat JP; REVA Research Network. Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece. N Engl J Med. 2022 Nov 17;387(20):1843-1854. doi: 10.1056/NEJMoa2209041. Epub 2022 Oct 26.
PubMed 36286317van Oosten JP, Akoumianaki E, Jonkman AH. Monitoring respiratory muscles effort during mechanical ventilation. Curr Opin Crit Care. 2025 Feb 1;31(1):12-20. doi: 10.1097/MCC.0000000000001229. Epub 2024 Nov 14.
PubMed 39560150Bertoni M, Telias I, Urner M, Long M, Del Sorbo L, Fan E, Sinderby C, Beck J, Liu L, Qiu H, Wong J, Slutsky AS, Ferguson ND, Brochard LJ, Goligher EC. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care. 2019 Nov 6;23(1):346. doi: 10.1186/s13054-019-2617-0.
PubMed 31694692
Study at a glance
From the registry record, last updated by the sponsor on 25 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective Observational Single-Center Physiological Study Evaluating Dynamic Stress Estimated by Delta Pocc During a Pressure Support Spontaneous Breathing Trial (PSV 8 cmH2O, PEEP 0 cmH2O) as a Predictor of Extubation Failure in Mechanically Ventilated Adult ICU Patients
- ClinicalTrials.gov ID
- NCT07634783
- Acronym / sponsor ID
- DELTA-EXT / SP-DELTAPOCC-EXTFAIL-2026
- Conditions
- Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness
- Keywords
- ΔPocc Spontaneous Breathing Trial Extubation Failure Weaning Respiratory Effort
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Sanatorio Parque, ArgentinaUniversity, hospital or other
- Study start
- Aug 2026 (estimated)
- Primary completion
- Aug 2027 (estimated)
- Study completion
- Aug 2027 (estimated)
- First posted
- 9 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective observational single-center study will evaluate whether dynamic respiratory stress estimated by delta airway occlusion pressure deflection (Delta Pocc) during a standardized spontaneous breathing trial can predict extubation failure in mechanically ventilated adult intensive care unit patients.
Liberation from invasive mechanical ventilation is a critical step in ICU care. Although spontaneous breathing trials are routinely used to assess readiness for extubation, some patients may successfully complete the trial despite experiencing excessive respiratory effort and physiological stress, which may increase the risk of extubation failure.
This study will include adult ICU patients who have received invasive mechanical ventilation for at least 24 hours and are considered ready for a spontaneous breathing trial according to the treating clinical team. During the trial, respiratory, ventilatory, and hemodynamic variables will be recorded at predefined time points, including measurements of Delta Pocc as a non-invasive estimate of inspiratory effort and dynamic stress.
The primary outcome is extubation failure within 48 hours after extubation, defined as reintubation and/or the need for rescue non-invasive respiratory support due to post-extubation respiratory deterioration.
The study aims to determine whether this physiological measurement may improve risk stratification during weaning and complement conventional clinical decision-making.
Detailed description
Background
Liberation from invasive mechanical ventilation requires integration of clinical, hemodynamic, gas exchange, and physiological criteria. The spontaneous breathing trial (SBT) is a standard component of the weaning process and is commonly used to assess readiness for extubation. However, conventional clinical parameters may not fully capture the true respiratory workload experienced by the patient during the trial.
Some patients may tolerate a spontaneous breathing trial according to standard criteria while still developing excessive inspiratory effort and elevated dynamic respiratory stress, potentially predisposing them to post-extubation respiratory failure. Identifying these patients before extubation remains a major clinical challenge.
Delta airway occlusion pressure deflection (Delta Pocc), obtained during a brief expiratory occlusion maneuver, has emerged as a non-invasive physiological surrogate for inspiratory effort and dynamic transpulmonary stress. Incorporating this measurement into routine spontaneous breathing trial assessment may improve identification of patients at increased risk of extubation failure.
Objective
The primary objective of this study is to evaluate the predictive ability of Delta Pocc measured during a standardized spontaneous breathing trial to identify patients at risk of extubation failure within 48 hours.
Secondary objectives include:
To describe the temporal evolution of Delta Pocc and other respiratory physiological variables during the spontaneous breathing trial.
To compare respiratory effort and physiological measurements between patients with successful extubation and those with extubation failure.
To explore the discriminatory performance of Delta Pocc compared with conventional weaning variables.
To evaluate associations between Delta Pocc and clinically relevant outcomes including reintubation, rescue respiratory support, ICU length of stay, hospital length of stay, and mortality.
Study Design
This is a prospective, observational, single-center physiological study conducted in the adult intensive care unit of Sanatorio Parque.
The study does not modify standard clinical management. Participation will not delay extubation decisions or replace the clinical judgment of the treating team.
Study Population
Adult ICU patients receiving invasive mechanical ventilation for at least 24 hours who meet clinical criteria for a spontaneous breathing trial according to routine clinical practice will be eligible.
Inclusion Criteria Age 18 years or older Invasive mechanical ventilation for at least 24 hours Clinical indication for spontaneous breathing trial Hemodynamic and clinical stability Technical feasibility for physiological measurements Exclusion Criteria Significant hemodynamic instability Severe uncontrolled hypoxemia Major arrhythmias Agitation or patient-ventilator asynchrony preventing reliable measurements Significant air leak Technical inability to perform expiratory occlusion maneuver Limitation of life-sustaining treatment Procedures
Baseline respiratory, ventilatory, and hemodynamic variables will be recorded under current ventilatory settings.
A standardized spontaneous breathing trial will then be performed using:
Pressure support ventilation (PSV): 8 cmH2O Positive end-expiratory pressure (PEEP): 0 cmH2O
Measurements will be recorded at:
Baseline 15 minutes 30 minutes
Collected variables include:
Delta Pocc P0.1 Estimated inspiratory muscle pressure Negative inspiratory force Respiratory rate Rapid shallow breathing index Minute ventilation Peak airway pressure Mean airway pressure Oxygen saturation Heart rate Blood pressure Mean arterial pressure Fraction of inspired oxygen
Extubation decisions, preventive non-invasive respiratory support, rescue respiratory support, and reintubation will remain entirely at the discretion of the treating clinical team according to institutional practice.
Outcomes Primary Outcome
Extubation failure within 48 hours after extubation, defined as:
Reintubation, and/or Rescue non-invasive respiratory support due to respiratory deterioration after extubation Secondary Outcomes Spontaneous breathing trial success or failure Cause of spontaneous breathing trial failure Preventive non-invasive respiratory support Reintubation Rescue non-invasive respiratory support Duration of mechanical ventilation ICU length of stay Total hospital length of stay In-hospital mortality Statistical Considerations
The study is designed to evaluate the discriminative performance of Delta Pocc as a predictor of extubation failure.
Receiver operating characteristic (ROC) analysis will be used to assess predictive performance. Repeated physiological measurements will be analyzed using appropriate repeated-measures statistical methods. Multivariable logistic regression may be performed if the number of outcome events is sufficient.
A planned sample size of approximately 110 to 120 patients is expected to provide adequate event capture for exploratory predictive modeling.
Safety
This is a minimal-risk observational study. The only study-specific physiological maneuver is a brief expiratory occlusion measurement performed within standard ventilatory monitoring conditions.
No investigational drugs or devices are involved.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Mechanically Ventilated Adult ICU Patients Undergoing Spontaneous Breathing Trial | – | Diagnostic Test: Delta Pocc Measurement During Spontaneous Breathing Trial |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult intensive care unit patients receiving invasive mechanical ventilation for at least 24 hours who are considered clinically ready for a spontaneous breathing trial as part of routine weaning assessment.
Key inclusion criteria (5 listed)
- Age 18 years or older
- Invasive mechanical ventilation for at least 24 hours
- Clinical indication for spontaneous breathing trial according to the treating clinical team
- Hemodynamic and clinical stability
- Technical feasibility for respiratory physiological measurements, including expiratory occlusion maneuver
Key exclusion criteria (8 listed)
- Significant hemodynamic instability
- Severe uncontrolled hypoxemia
- Major cardiac arrhythmias
- Agitation or patient-ventilator asynchrony preventing reliable measurements
- Significant air leak interfering with respiratory measurements
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Delta Pocc Measurement During Spontaneous Breathing TrialDelta airway occlusion pressure deflection will be measured during a standardized spontaneous breathing trial using pressure support ventilation of 8 cmH2O and PEEP of 0 cmH2O. Delta Pocc will be obtained through a brief expiratory occlusion maneuver and analyzed as a non-invasive physiological estimate of inspiratory effort and dynamic respiratory stress. The measurement will not replace clinical judgment or modify standard extubation decisions. | Diagnostic test | Mechanically Ventilated Adult ICU Patients Undergoing Spontaneous Breathing Trial |
Primary outcome
Number of Participants With Extubation Failure Within 48 Hours
Time frame: Within 48 hours after extubation
Number of participants experiencing extubation failure, defined as reintubation and/or the need for rescue non-invasive respiratory support due to respiratory deterioration after extubation.
6 secondary outcomes
Change in Delta Pocc During the Spontaneous Breathing Trial
Time frame: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
P0.1 During the Spontaneous Breathing Trial
Time frame: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Number of Participants Requiring Reintubation
Time frame: Within 48 hours after extubation
Number of Participants Requiring Rescue Non-Invasive Respiratory Support
Time frame: Within 48 hours after extubation
Intensive Care Unit Length of Stay
Time frame: Through ICU discharge, an average of 30 days
Number of Participants Who Died During Hospitalization
Time frame: Through hospital discharge, an average of 60 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jun 2026.
- Background: PubMed 36286317Thille AW, Gacouin A, Coudroy R, Ehrmann S, Quenot JP, Nay MA, Guitton C, Contou D, Labro G, Reignier J, Pradel G, Beduneau G, Dangers L, Saccheri C, Prat G, Lacave G, Sedillot N, Terzi N, La Combe B, Mira JP, Romen A, Azais MA, Rouze A, Devaquet J, Delbove A, Dres M, Bourenne J, Lautrette A, de Keizer J, Ragot S, Frat JP; REVA Research Network. Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece. N Engl J Med. 2022 Nov 17;387(20):1843-1854. doi: 10.1056/NEJMoa2209041. Epub 2022 Oct 26.
- Background: PubMed 39560150van Oosten JP, Akoumianaki E, Jonkman AH. Monitoring respiratory muscles effort during mechanical ventilation. Curr Opin Crit Care. 2025 Feb 1;31(1):12-20. doi: 10.1097/MCC.0000000000001229. Epub 2024 Nov 14.
- Background: PubMed 31694692Bertoni M, Telias I, Urner M, Long M, Del Sorbo L, Fan E, Sinderby C, Beck J, Liu L, Qiu H, Wong J, Slutsky AS, Ferguson ND, Brochard LJ, Goligher EC. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care. 2019 Nov 6;23(1):346. doi: 10.1186/s13054-019-2617-0.
- Individual participant dataSharing planned: No. Individual participant data are not planned to be shared because this is a single-center observational study and no formal institutional data-sharing infrastructure is currently in place. De-identified aggregate study results will be reported in scientific publications.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Gabriel A Musso, PT, MSc principal investigator
Sanatorio Parque
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness, run by Sanatorio Parque, Argentina at 1 site in Argentina.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Argentina. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Gabriel A Musso, PT, MSc (+54 9 3413068143, udikcar@ugr.edu.ar), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Participants With Extubation Failure Within 48 Hours (time frame: Within 48 hours after extubation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07634783, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.